AAS
OCUL icon

Ameritas Advisory Services’s Ocular Therapeutix OCUL Stock Holding History

Ameritas Advisory Services’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79K Buy
+284
New +$2.57K ﹤0.01% 1650
2025
Q3 		– Sell
-291
Closed -$2.7K – 2667
2025
Q2 		$2.7K Buy
+291
New +$2.28K ﹤0.01% 2422

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameritas Advisory Services's OCUL Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in Ocular Therapeutix (OCUL) in Q2 2026: 284 shares worth $2.79K. The stake represents ﹤0.01% of the portfolio and ranks #1650 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in OCUL as recently as Q2 2025.

Ameritas Advisory Services first reported a position in OCUL in Q2 2025 and has held it in 2 quarters since. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Ameritas Advisory Services held 284 shares of Ocular Therapeutix worth $2.79K as of Q2 2026.
  • Ocular Therapeutix was a new Ameritas Advisory Services position in Q2 2026.
  • Ocular Therapeutix made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1650 holding.
  • Ameritas Advisory Services first reported a position in Ocular Therapeutix in Q2 2025 and has held it in 2 quarters since.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.